This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Mark Your Calendar for Next Year's Event!
May 9-12, 2022Hynes Convention Center, Boston

Industry’s Largest & Most Renowned Event to Accelerate Your Therapeutics to Market: Leading Strategies for Expediting R&D and Improving CMC Efficiency

Thank you to the 1300+ in person and digital participants of TIDES USA 2021 Hybrid!

Both in-person and digital attendees at this year's event may still access our ConnectMe digital event platform through end of October 2021 to watch presentation recordings, view the virtual exhibits/posters and chat with fellow attendees.  Mark your calendar to join us at next year's event as we return to Boston on May 9-12, 2022.

TIDES Expert Opinion Webinar Series

Nucleic Acid–based Therapies: Challenges and Opportunities during Nonclinical Development

30 Min Webinar + Q&A | 11:00AM EST | October 20th | Sponsored by: Charles River

LEARN FROM THE BRIGHTEST MINDS IN THE OLIGONUCLEOTIDE, PEPTIDE & MRNA THERAPEUTICS INDUSTRY

Each year, TIDES' scientific agenda includes 150+ of the industry's top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products. 

DOWNLOAD THE CONNECTME APP FOR THE PREMIUM EVENT EXPERIENCE


Before arriving in Boston,  registered attendees should download the new ConnectMe App to unlock these benefits:

  • Access the latest agenda, live polling, speaker Q&A and Room Radar to see who else is sitting in the room with you
  • See who else is attending, create connections, book meetings, chat and video call
  • Play the at venue game to help us plant a Million Mangroves  – a project we can all enjoy supporting, as a part of our wider commitment to delivering a sustainable event
  • Interact with exhibitors and add content into your personal digital bag
  • Access digital copies of scientific posters
  • Win prizes by scanning exhibitor QR codes in the exhibit hall

ACCESS NOVEL SCIENCE ACROSS THE ENTIRE OLIGONUCLEOTIDE, PEPTIDE, AND MRNA SPECTRUM

Cross-fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas.

The TIDES USA program features 4 concurrent tracks covering the following 6 scientific themes including in-depth development strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing. Your registration provides access to the presentations across all 4 tracks, allowing you to create your own customized agenda.

Oligonucleotide Chemistry, Manufacturing & Controls

Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.

Oligonucleotide Discovery, Preclinical and Clinical

Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

Peptide Chemistry, Manufacturing & Controls

Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.

Peptide Discovery, Preclinical and Clinical

Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

mRNA Therapeutics/Vaccines & Genome Editing

Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies, and learn about state-of-the-art technologies for genome editing applications and hear about progress in genome editing delivery

Drug Delivery Innovations

Explore new technologies and approaches in the delivery of macromolecular therapeutics featuring multiple case studies of the delivery of oligonucleotides, peptides, mRNA therapeutics and genome editing delivery strategies. Learn about cutting-edge delivery advances including targeted delivery approaches for oligonucleotides, device-based delivery strategies and oral delivery of peptides.

CONNECT WITH THE INDUSTRY ANYWHERE IN THE WORLD

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals. Our 2021 hybrid event will offer you the most flexibility needed during these uncertain times. 

For more information, click the link below or email Mike Dunnet directly at mdunnet@informaconnectls.com.

Looking for Additional Training Opportunities?

Join us at one of our upcoming virtual TIDES training courses.

Informa training courses provide in-depth teaching and discussion about highly technical and scientific topics relevant to the TIDES community that can not be covered at a conference. With 6+ hours of dedicated instruction in a classroom-like (teacher/student) environment, a training course will offer you interactive opportunities with the instructor and fellow attendees so you can get your most pressing questions answered in a much more individualized setting.

Introduction to Oligonucleotide Conjugate Strategies

October 26-28 (Virtual)
Understand how to best design oligonucleotide conjugates — from simple starting building blocks to the full oligonucleotide conjugate. With full consideration of the biological behavior of both the finished molecule and all of its individual components.

Informa AllSecure is Informa’s approach to enhanced health and safety standards at our events following COVID-19

Jesper Lau, Ph.D.

VP, Protein and Peptide Chemistry

Novo Nordisk, Denmark

The yearly TIDES conferences are among the most important events within peptide and oligonucleotide discovery and development and it has always been among my high priority to be able to join them. I am thus delighted to learn that Informa Connect will deliver TIDES USA Boston 2020 in a virtual format, and I am convinced that a digital meeting will be extremely appreciated in order to continue the important global communication among the scientific communities during these tough times.